Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on September 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Combines Synopsis Solicitation- NULISAseq Inflamma

Closed
75N98026Q01133Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
Joliet Job Corps-Request for Quote Asbestos Testing & Abatement
Solicitation # Joliet JCC Asbestos Testing & Abatement
Management & Training Corporation is seeking quotes for a fee-for-service subcontracting opportunity to provide asbestos testing and abatement services at the Joliet Job Corps center in Joliet, Illinois. The scope of work includes sampling and laboratory analysis of ceiling tiles in the Administration Academic Building and Welcome Center, as well as testing and the potential removal and disposal of approximately 600 square feet of asbestos-containing material from the gymnasium floor. All work must be performed by licensed professionals using accredited laboratories and must comply with federal, State of Illinois, OSHA, and EPA regulations. Key deliverables include a sampling plan, waste shipment records, and a final project completion report. This solicitation is open to various small business categories, including VOSB, SDVOSB, WOSB, and HUBZone certified firms. Interested bidders must submit a bid sheet, a completed supplier packet containing a W-9 and self-certification, proof of insurance, and three references for similar projects by October 21, 2026. Award selection is based on best value. The contract is subject to Service Contract Labor Standards, specifically Wage Determination No. 2015-5019 Rev. 31, and includes various FAR clauses regarding small business utilization, minimum wages, and the combating of trafficking in persons. Subcontractors are also required to maintain a Unique Entity Identifier (UEI) for reporting purposes.
Joliet Job Corps

POSTED

about 7 hours ago

DEADLINE

in about 7 hours

AI Contract Overview

Show more

Solicitation 75N98026Q01133 is a combined synopsis and request for quotation issued by the National Institutes of Health Office of Logistics and Office of Administration. The government is seeking an Inflammation Panel service to profile over 250 biomarkers of inflammation and immune response within cerebral organoids samples. Technical requirements specify a high sensitivity capable of detecting proteins at fg/ml levels from sample volumes as low as 10ul, and a 12 logs dynamic range without the need for dilution. The expected delivery for these services is within 30 days after receipt of the order, with the place of performance located in Bethesda, Maryland. This acquisition is conducted as a non-competitive, firm-fixed price award based on best value, utilizing the authority of FAR Part 12.603 for streamlined solicitations of commercial products or services. While there are conflicting notes regarding set-aside status, the solicitation is associated with NAICS code 541380 and a business size standard of 19 million dollars. Interested offerors must be registered in the System for Award Management and provide a completed FAR 52.212-3 certification, UEI, and TIN. Proposals must be submitted electronically to the designated point of contact by September 11, 2026, at 12:00 PM EST, and must include detailed pricing, including unit and list prices, shipping costs, and delivery timeframes.

General Info

NIH non-competitive solicitation 75N98026Q01133 for NULISAseq Inflamma, due September 11, 2026.

NAICS

541380 - Testing Laboratories and Services

Place of Performance

MD

Set-Aside

NONE

Documents

1

RFQ 75N98026Q01133 - Request for Quotation

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q01133 and the solicitation is issued as a Notice of Intent (NOI) of a non-competitive (notice of intent) combined synopsis solicitation to award a contract or purchase order without providing for full or open competition (including brand-name).

This acquisition is conducted under the authority of the FAR Part 12.603¿ Streamlined solicitation for commercial products or commercial services, and is not expected to exceed the simplified acquisition threshold, and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii).

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 325411
New
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 14 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS